These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease. Smith R; Liu M; Liby T; Bayani N; Bucher E; Chiotti K; Derrick D; Chauchereau A; Heiser L; Alumkal J; Feiler H; Carroll P; Korkola JE Sci Rep; 2020 Dec; 10(1):21750. PubMed ID: 33303959 [TBL] [Abstract][Full Text] [Related]
8. Targeting the PI3K/AKT Pathway Overcomes Enzalutamide Resistance by Inhibiting Induction of the Glucocorticoid Receptor. Adelaiye-Ogala R; Gryder BE; Nguyen YTM; Alilin AN; Grayson AR; Bajwa W; Jansson KH; Beshiri ML; Agarwal S; Rodriguez-Nieves JA; Capaldo B; Kelly K; VanderWeele DJ Mol Cancer Ther; 2020 Jul; 19(7):1436-1447. PubMed ID: 32371590 [TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer. Isikbay M; Otto K; Kregel S; Kach J; Cai Y; Vander Griend DJ; Conzen SD; Szmulewitz RZ Horm Cancer; 2014 Apr; 5(2):72-89. PubMed ID: 24615402 [TBL] [Abstract][Full Text] [Related]
10. TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growth. Palit SA; Vis D; Stelloo S; Lieftink C; Prekovic S; Bekers E; Hofland I; Šuštić T; Wolters L; Beijersbergen R; Bergman AM; Győrffy B; Wessels LF; Zwart W; van der Heijden MS Elife; 2019 Dec; 8():. PubMed ID: 31855178 [TBL] [Abstract][Full Text] [Related]
11. Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer. Shah N; Wang P; Wongvipat J; Karthaus WR; Abida W; Armenia J; Rockowitz S; Drier Y; Bernstein BE; Long HW; Freedman ML; Arora VK; Zheng D; Sawyers CL Elife; 2017 Sep; 6():. PubMed ID: 28891793 [TBL] [Abstract][Full Text] [Related]
12. PEG10 is associated with treatment-induced neuroendocrine prostate cancer. Kim S; Thaper D; Bidnur S; Toren P; Akamatsu S; Bishop JL; Colins C; Vahid S; Zoubeidi A J Mol Endocrinol; 2019 Jul; 63(1):39-49. PubMed ID: 31013476 [TBL] [Abstract][Full Text] [Related]
13. The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer. Bishop JL; Thaper D; Vahid S; Davies A; Ketola K; Kuruma H; Jama R; Nip KM; Angeles A; Johnson F; Wyatt AW; Fazli L; Gleave ME; Lin D; Rubin MA; Collins CC; Wang Y; Beltran H; Zoubeidi A Cancer Discov; 2017 Jan; 7(1):54-71. PubMed ID: 27784708 [TBL] [Abstract][Full Text] [Related]
14. SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway Inhibition. Li Y; Donmez N; Sahinalp C; Xie N; Wang Y; Xue H; Mo F; Beltran H; Gleave M; Wang Y; Collins C; Dong X Eur Urol; 2017 Jan; 71(1):68-78. PubMed ID: 27180064 [TBL] [Abstract][Full Text] [Related]
15. Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancer. Puhr M; Eigentler A; Handle F; Hackl H; Ploner C; Heidegger I; Schaefer G; Brandt MP; Hoefer J; Van der Pluijm G; Klocker H Oncogene; 2021 Apr; 40(17):3087-3100. PubMed ID: 33795839 [TBL] [Abstract][Full Text] [Related]
19. ONECUT2 is a driver of neuroendocrine prostate cancer. Guo H; Ci X; Ahmed M; Hua JT; Soares F; Lin D; Puca L; Vosoughi A; Xue H; Li E; Su P; Chen S; Nguyen T; Liang Y; Zhang Y; Xu X; Xu J; Sheahan AV; Ba-Alawi W; Zhang S; Mahamud O; Vellanki RN; Gleave M; Bristow RG; Haibe-Kains B; Poirier JT; Rudin CM; Tsao MS; Wouters BG; Fazli L; Feng FY; Ellis L; van der Kwast T; Berlin A; Koritzinsky M; Boutros PC; Zoubeidi A; Beltran H; Wang Y; He HH Nat Commun; 2019 Jan; 10(1):278. PubMed ID: 30655535 [TBL] [Abstract][Full Text] [Related]
20. Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance. Ku SY; Rosario S; Wang Y; Mu P; Seshadri M; Goodrich ZW; Goodrich MM; Labbé DP; Gomez EC; Wang J; Long HW; Xu B; Brown M; Loda M; Sawyers CL; Ellis L; Goodrich DW Science; 2017 Jan; 355(6320):78-83. PubMed ID: 28059767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]